摘要
Duchenne型肌营养不良症是一种变异表达的疾病,是由于基因突变而引起的。其特点是进行性肌肉无力和扩张型心肌病。帧内营养不良蛋白突变引起一种临床中度疾病,名为Becker肌营养不良症。我们的目的是研究遗传性心肌病和贝克肌营养不良症家族的临床和遗传特征。5岁时诊断为精神运动性迟滞。12岁时出现不对称左室肥厚和长QT间期。随后出现轻度肌肉无力。在该指数病例中发现了3个遗传变异:MYBPC 3基因的P.Arg891Alafs*160,KCNJ 5基因的p.Thr263Met和DMD基因中的p.Ser2437_Ile2554delinsPhe。后者将产生dystrophin基因第51和52号外显子的帧内缺失。一项家庭研究显示,父亲和3位叔叔是MYBPC 3突变的携带者。母亲和外祖父是另外两个变体的携带者。这位80岁的祖父患有肌营养不良蛋白突变,没有心肌病或肌肉无力的迹象。DMD基因外显子51和52的缺失已被认为是Duchenne的治疗策略之一,这与正常的预期寿命和无肌疾病症状的半男性是一致的。
关键词: Duchenne肌营养不良,心肌病,肌营养不良,外显子,缺失,MYBPC 3,肌无力症状。
Current Gene Therapy
Title:Phenotypic Characterization of a Family With An In-frame Deletion in the DMD Gene and Variable Penetrance
Volume: 18 Issue: 4
关键词: Duchenne肌营养不良,心肌病,肌营养不良,外显子,缺失,MYBPC 3,肌无力症状。
摘要: Duchenne muscular dystrophy is a disorder with variable expression caused by framedisrupting mutations in the dystrophin gene. It is characterized by progressive muscle weakness and dilated cardiomyopathy. In-frame dystrophin mutations cause a clinically moderate disorder named Becker muscular dystrophy. Our aim was to study the clinical and genetic characteristics of a family with inherited cardiomyopathy and Becker muscular dystrophy.
The index case was diagnosed with psychomotor retardation at 5 years of age. Asymmetric left ventricular hypertrophy and a long QT interval were evidenced at the age of 12. Mild muscular weakness was developed subsequently. Three genetic variants were identified in the index case: p.Arg891Alafs*160 in the MYBPC3 gene, p.Thr263Met in the KCNJ5 gene, and p.Ser2437_Ile2554delinsPhe in the DMD gene. The latter was expected to generate an in-frame deletion of exons 51 and 52 of the dystrophin gene.
A family study revealed that the father and 3 uncles were carriers of the MYBPC3 mutation. The mother and a maternal grandfather were carriers of the other 2 variants. The 80-year-old grandfather, who had the dystrophin mutation, showed no sign of cardiomyopathy or muscular weakness.
The deletion of exons 51 and 52 in the DMD gene, which has been proposed as one of the therapeutic strategies for Duchenne, is consistent with a normal life expectancy and the absence of myopathic symptoms in hemizygous males.
Export Options
About this article
Cite this article as:
Phenotypic Characterization of a Family With An In-frame Deletion in the DMD Gene and Variable Penetrance, Current Gene Therapy 2018; 18 (4) . https://dx.doi.org/10.2174/1566523218666180709125346
DOI https://dx.doi.org/10.2174/1566523218666180709125346 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Tissue Engineering Techniques in Cardiac Repair and Disease Modelling
Current Pharmaceutical Design Truncated Human Cathepsin L, Encoded by a Novel Splice Variant, Exhibits Altered Subcellular Localization and Cytotoxicity
Protein & Peptide Letters FoxO3a Governs Early Microglial Proliferation and Employs Mitochondrial Depolarization with Caspase 3, 8, and 9 Cleavage During Oxidant Induced Apoptosis
Current Neurovascular Research Gene Therapy in Liver Diseases: State-of-the-Art and Future Perspectives
Current Gene Therapy Recent Advancements in Diagnosis and Therapy of Liver Cirrhosis
Current Drug Targets Selective Divalent Copper Chelation for the Treatment of Diabetes Mellitus
Current Medicinal Chemistry Stable Gastric Pentadecapeptide BPC 157-NO-system Relation
Current Pharmaceutical Design Prediction of Degeneration of Native and Bioprosthetic Aortic Valves:Issue-Related Particularities of Diabetes Mellitus
Infectious Disorders - Drug Targets Beta3-Adrenoreceptors in Cardiovasular Diseases: New Roles for an “Old” Receptor
Current Drug Delivery Current State of Development of Genome Analysis in Livestock
Current Genomics Gene Clusters, Molecular Evolution and Disease: A Speculation
Current Genomics Obesity in the Cardiovascular Continuum
Current Clinical Pharmacology Research Advancements in Porcine Derived Mesenchymal Stem Cells
Current Stem Cell Research & Therapy Biomarkers of Protein Oxidation in Human Disease
Current Molecular Medicine Oxidative Stress and Mitochondrial Dysfunction in Type 2 Diabetes
Current Pharmaceutical Design Stem Cell Pharmacogenomics
Current Topics in Medicinal Chemistry COVID-19 Invades Several Important Organs other than the Lungs: Organs Crosstalk
Coronaviruses The Role of Negative Costimulators During Parasitic Infections
Endocrine, Metabolic & Immune Disorders - Drug Targets The Role of Oxidative Stress in Smoking-Related Diseases
Mini-Reviews in Organic Chemistry Diabetes Mellitus: Channeling Care through Cellular Discovery
Current Neurovascular Research